摘要:
Disclosed are pyroglutamic acid derivatives and related compounds which bind VLA-4. Certain of these compounds also inhibit leukocyte adhesion and, in particular, leukocyte adhesion mediated by VLA-4. Such compounds are useful in the treatment of inflammatory diseases in a mammalian patient, e.g., human, such as asthma, Alzheimer's disease, atherosclerosis, AIDS dementia, diabetes, inflammatory bowel disease, rheumatoid arthritis, tissue transplantation, tumor metastasis and myocardial ischemia. The compounds can also be administered for the treatment of inflammatory brain diseases such as multiple sclerosis.
摘要:
The compounds of formula (I), wherein R?1, R4 and R5¿ are, independently, hydrogen, alkyl, alkoxy, aralkoxy, alkanoyloxy, hydroxy, halo, trifluoromethyl, amino, mono- or di-alkylamino, alkanamido, or alkanesulfonamido; or, R1 is defined as above and R?4 and R5¿, taken together, are ortho substituted methylenedioxy, ethylenedioxy, or propylenedioxy; R?2 and R3¿ are, independently, hydrogen or alkyl; n is 3 or 4; or pharmaceutically acceptable salts thereof, are useful in the treatment of depression and related disorders.
摘要:
The compounds of formula (I), wherein R?1, R4 and R5¿ are, independently, hydrogen, alkyl, alkoxy, aralkoxy, alkanoyloxy, hydroxy, halo, trifluoromethyl, amino, mono- or di-alkylamino, alkanamido, or alkanesulfonamido; or, R1 is defined as above and R?4 and R5¿, taken together, are ortho substituted methylenedioxy, ethylenedioxy, or propylenedioxy; R?2 and R3¿ are, independently, hydrogen or alkyl; n is 3 or 4; or pharmaceutically acceptable salts thereof, are useful in the treatment of depression and related disorders.
摘要:
The compounds of formula (I) wherein X is H2 or O; R1 is hydrogen, hydroxy, halo, trifluoromethyl, trifluoromethoxy, alkyl, alkoxy, aralkoxy, alkanoyloxy, amino, mono- or di-alkylamino, alkanamido or alkanesulfonamido; Z is defined by formula (II), (III) or (IV) wherein R2 is hydrogen, alkyl, cycloalkyl, phenyl optionally substituted with R1 as defined above, φ-phenylalkyl or φ-diphenylalkyl, in which the phenyl ring is optionally substituted with R1 as defined above, or R2 is naphthyl, indolyl, indazolyl, thienyl, pyridinyl, pyrimidinyl, quinolinyl, benzoisothiazolyl or benzisoxazolyl, each optionally substituted with R1 as defined above; R3 is hydrogen and R4 is hydrogen, 1-benzimidazolyl-2-one, indolyl, benzoisothiazolyl or benzisoxazolyl, each optionally substituted with R1 as defined above, or R4 is -Y-Ar, in which Y is C=O, CHOH, or (CH¿2?)m, wherein m is 0 to 4, and Ar is phenyl, optionally substituted with R?1¿ as defined above; or R?3 and R4¿, taken together with the carbon atom to which they are attached form (V) or (VI) in which R5 is hydrogen and R6 is phenyl, naphthyl, thienyl, indolyl, benzoisothiazolyl or benzisoxazolyl, each optionally substituted with R1 as defined above; or R?5 and R6¿, taken together with the carbon atoms to which they are attached complete a benzene ring optionally substituted with R1; or a pharmaceutically acceptable salt thereof; are useful for the treatment of brain dopamine dysregulation.
摘要:
A compound of formula (1), wherein R?1 and R2¿ are, independently, hydrogen, alkyl, alkoxy, aralkoxy, alkanoyloxy, hydroxy, halo, amino, mono- or dialkylamino, alkanamido or sulfonamido, or R?1 and R2¿ together are methylenedioxy, ethylenedioxy or propylenedioxy; R3 is hydrogen or alkyl; n is one of the integers 2, 3 or 4; or a pharmaceutically acceptable salt thereof, are antipsychotic agents.
摘要:
Disclosed are pyroglutamic acid derivatives and related compounds which bind VLA-4. Certain of these compounds also inhibit leukocyte adhesion and, in particular, leukocyte adhesion mediated by VLA-4. Such compounds are useful in the treatment of inflammatory diseases in a mammalian patient, e.g., human, such as asthma, Alzheimer's disease, atherosclerosis, AIDS dementia, diabetes, inflammatory bowel disease, rheumatoid arthritis, tissue transplantation, tumor metastasis and myocardial ischemia. The compounds can also be administered for the treatment of inflammatory brain diseases such as multiple sclerosis.